Abstract: The current document is directed to methods and subsystems that manage submitted code changes for processing by continuous-integration/continuous-delivery/deployment systems. In disclosed implementations, code changes are processed as quickly as possible, when the code changes are flagged as being urgent. Non-urgent code changes are evaluated for the possibility of merging the non-urgent code changes with additional, subsequently submitted code changes in order to more efficiently employ computational resources needed for processing the code changes. When there is a code change, waiting for processing, with which a submitted code change can be merged, the submitted code change is merged with the waiting code change so that the merged code changes can be together verified.

Abstract: The health of a distributed storage system provided by a virtualized computing environment may be evaluated. The evaluation techniques categorize health issues based on at least three categories (e.g., storage data availability and accessibility, storage data performance, and storage space utilization and efficiency), and provide priority levels for the health issues within each category. In this manner, a more user-oriented approach is provided wherein in addition to identifying health issues, the priority/urgency level of the health issue(s) can be provided so as to guide the user (such as a system administrator) in determining an appropriate remedial action to perform and when such remedial action should be performed to address health issues.

Abstract: The present disclosure relates to a benzimidazole-substituted phenyl-n-butyramide-based compound and the preparation method thereof. The method of the present disclosure avoids nitration reaction and polyphosphoric acid cyclization reaction, and avoids the generation of a large amount of waste acid reaction solution from the source. The synthesis method embodied in the invention has the advantages of simplicity and high efficiency, mild conditions and few pollutants, etc., and is suitable to be developed as a green and sustainable production process.

Abstract: The present invention relates to a fused ring compound represented by general formula (I), a stereoisomer or a pharmaceutically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition and use thereof. The compound provided in the present invention is useful for treating, preventing and/or controlling various nervous system disorders. The compound provided in the present invention modulates one or more monoamine transporters, inhibits the reuptake of endogenous monoamines such as dopamine, 5-hydroxytryptamine, and norepinephrine (e.g., from the synaptic cleft), and/or modulates the 5-HT3 receptor.